Necrosis Completed Phase Trials for Everolimus (DB01590)

Also known as: Necrotic / Necrosis NOS

IndicationStatusPhase
DBCOND0012371 (Necrosis)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT0446231510-Years Follow-up of the EXAMINATION Trial